Antipsychotics, mood stabilisers, and risk of violent crime

被引:165
作者
Fazel, Seena [1 ]
Zetterqvist, Johan [2 ]
Larsson, Henrik [2 ]
Langstroem, Nikfas [2 ]
Lichtenstein, Paul [2 ]
机构
[1] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England
[2] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
BIPOLAR DISORDER; SCHIZOPHRENIA; MEDICATIONS; TRENDS; INTERVENTIONS; METAANALYSIS; AGGRESSION; PREVENTION; MORTALITY; REGISTER;
D O I
10.1016/S0140-6736(14)60379-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Antipsychotics and mood stabilisers are prescribed widely to patients with psychiatric disorders worldwide. Despite clear evidence for their efficacy in relapse prevention and symptom relief, their effect on some adverse outcomes, including the perpetration of violent crime, is unclear. We aimed to establish the effect of antipsychotics and mood stabilisers on the rate of violent crime committed by patients with psychiatric disorders in Sweden. Methods We used linked Swedish national registers to study 82 647 patients who were prescribed antipsychotics or mood stabilisers, their psychiatric diagnoses, and subsequent criminal convictions in 2006-09. We did withinindividual analyses to compare the rate of violent criminality during the time that patients were prescribed these medications versus the rate for the same patients while they were not receiving the drugs to adjust for all confounders that remained constant within each participant during follow-up. The primary outcome was the occurrence of violent crime, according to Sweden's national crime register. Findings In 2006-09, 40 937 men in Sweden were prescribed antipsychotics or mood stabilisers, of whom 2657 (6.5%) were convicted of a violent crime during the study period. In the same period, 41 710 women were prescribed these drugs, of whom 604 (1.4 %) had convictions for violent crime. Compared with periods when participants were not on medication, violent crime fell by 45% in patients receiving antipsychotics (hazard ratio [HR] 0.55, 95% CI 0.47-0.64) and by 24% in patients prescribed mood stabilisers (0. 76, 0.62-0.93). However, we identified potentially important differences by diagnosis mood stabilisers were associated with a reduced rate of violent crime only in patients with bipolar disorder. The rate of violence reduction for antipsychotics remained between 22% and 29% in sensitivity analyses that used different outcomes (any crime, drug-related crime, less severe crime, and violent arrest), and was stronger in patients who were prescribed higher drug doses than in those prescribed low doses. Notable reductions in violent crime were also recorded for depot medication (HR adjusted for concomitant oral medications 0. 60, 95% CI 0.39-0.92). Interpretation In addition to relapse prevention and psychiatric symptom relief, the benefits of antipsychotics and mood stabilisers might also include reductions in the rates of violent crime. The potential effects of these drugs on violence and crime should be taken into account when treatment options for patients with psychiatric disorders are being considered.
引用
收藏
页码:1206 / 1214
页数:9
相关论文
共 57 条
[1]   Fixed-effects partial likelihood for repeated events [J].
Allison, PD .
SOCIOLOGICAL METHODS & RESEARCH, 1996, 25 (02) :207-222
[2]  
[Anonymous], 2004, AM J PSYCHIAT
[3]   Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence [J].
Arango, C ;
Bombín, I ;
González-Salvador, T ;
García-Cabeza, I ;
Bobes, J .
EUROPEAN PSYCHIATRY, 2006, 21 (01) :34-40
[4]  
Baldwin DS., 2007, Advances in Psychiatric Treatment, V13, P414, DOI DOI 10.1192/APT.BP.107.004184
[5]   Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology [J].
Barnes, Thomas R. E. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (05) :567-620
[6]   Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials [J].
Beynon, S. ;
Soares-Weiser, K. ;
Woolacott, N. ;
Duffy, S. ;
Geddes, J. R. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (05) :574-591
[7]   Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis [J].
Cipriani, Andrea ;
Hawton, Keith ;
Stockton, Sarah ;
Geddes, John R. .
BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
[8]   Use of mood stabilizers among patients with schizophrenia, 1994-2001 [J].
Citrome, L ;
Jaffe, A ;
Levine, J ;
Allingham, B .
PSYCHIATRIC SERVICES, 2002, 53 (10) :1212-1212
[9]   The psychopharmacology of violence with emphasis on schizophrenia, part 2: Long-term treatment [J].
Citrome, Leslie .
JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (02) :331-332
[10]  
Citrome L, 2010, PSYCHIAT SERV, V61, P9, DOI 10.1176/appi.ps.61.1.9